ÂÜŔňÂŇÂ×

The Scientific Research and Development team at CDI Labs spearheads the innovative exploration and characterization of proteins using advanced proteomics and synthetic biology techniques. Leveraging extensive proteomic libraries, including the industry-leading HuProt™ array and PhIP-Seq technology, the team focuses on human autoantibody seromics discovery, protein-protein interactions, pinpointing target IDs of unknown binders, and enhancing antibody specificity. Their collaborative efforts with companies and academic institutions drive pioneering solutions aimed at transforming our understanding of human health and disease.